NIH Guide for Grants and Contracts
April 17, 2020
Weekly NIH Funding Opportunities and Notices

General Notices

  • Request for Information (RFI): Invitation to Comment on Updates to NIH Research Plans on Down Syndrome
    (NOT-HD-20-013)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Office of the Director, NIH
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notice of Changes to Funding Opportunities

  • Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)."
    (NOT-NS-20-047)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute of Nursing Research
    Office of Research on Women's Health
  • Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-017 "HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)."
    (NOT-NS-20-048)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute of Nursing Research
    Office of Research on Women's Health
  • Notice of Change in Expiration Date and Cancellation of Final Three Receipt Dates for RFA-NS-19-018 "HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)."
    (NOT-NS-20-049)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute of Nursing Research
    Office of Research on Women's Health

Notices of Intent to Publish

Notices of Special Interest

Funding Opportunities

  • Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)
    (PAR-20-165)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Library of Medicine
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is June 5, 2020.

  • Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
    (PAR-20-167)
    National Institutes of Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Application Receipt Date(s): August 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)
    (PAR-20-168)
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): Standard dates apply . The first standard application due date for this FOA is June 1?6?, 2020. by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    (PAR-20-169)
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date The first standard application due date for this FOA is May 25, 2020.

  • New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)
    (PAR-20-170)
    National Cancer Institute
    Application Receipt Date(s): November 18, 2020; June 6, 2021; November 18, 2021; June 6, 2022; November 18, 2022; June 6, 2023

  • Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional)
    (RFA-AI-20-029)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): October 9, 2020

  • Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
    (RFA-CA-20-031)
    National Cancer Institute
    Application Receipt Date(s): July 24, 2020; June 24, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products (UC2) Clinical Trials Not Allowed
    (RFA-FD-21-003)
    Food and Drug Administration
    Application Receipt Date(s): July 10, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA

  • Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required)
    (RFA-HL-22-006)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): March 8, 2021

  • Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required)
    (RFA-MH-20-500)
    National Institute of Mental Health
    Application Receipt Date(s): October 19, 2020 and June 15,2021 No late applications will be accepted for the Funding Opportunity Announcement.